Propofol-related biological alterations and incidence of propofol infusion syndrome in status epilepticus: a 10-year cohort study
Prolonged propofol infusions warrant routine monitoring of specific biological markers. Our study identifies key parameters to follow and confirms that PRIS remains rare in specialized centers where patients are closely monitored and risk factors are carefully considered.
Authors
- Clémence Marois (ORCID: https://orcid.org/0000-0002-3266-0623)
- R. Bittar
- Nesrine Braham Ghedira
- Adam Celier (ORCID: https://orcid.org/0000-0002-3682-5413)
- Quentin Calonge (ORCID: https://orcid.org/0009-0004-5874-3947)
- Chanez Djahel
- Vincent Navarro
- Aurélie Hanin
- Léa Cosme
- Zineb Hayatou
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université Paris Cité (FR)
- Sorbonne Université (FR)
- Sorbonne Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Pitié-Salpêtrière Hospital (FR)
- Unité de Technologies Chimiques et Biologiques pour la Santé (FR)
- Institut du Cerveau (FR)
- Hôpital Charles-Foix (FR)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2026-01-21
- DOI
- https://doi.org/10.3389/fneur.2025.1753979
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00